SEC CIK 52848 · Series S000004450 · Portfolio as of 2026-05-31
| Security | Value | Weight |
|---|---|---|
| Eli Lilly & Co · LLY | $2.67B | 14.04% |
| Johnson & Johnson · JNJ | $1.61B | 8.47% |
| AbbVie Inc · ABBV | $1.16B | 6.08% |
| UnitedHealth Group Inc · UNH | $1.03B | 5.45% |
| Merck & Co Inc · MRK | $885.0M | 4.66% |
| Thermo Fisher Scientific Inc · TMO | $555.7M | 2.93% |
| Amgen Inc · AMGN | $544.7M | 2.87% |
| Gilead Sciences Inc · GILD | $500.9M | 2.64% |
| Intuitive Surgical Inc · ISRG | $452.1M | 2.38% |
| Pfizer Inc · PFE | $447.0M | 2.35% |
From N-PORT Part B, units verified by net-asset reconciliation.
curl "https://api.fundlens.io/v1/funds/VHCIX/holdings" \
-H "x-api-key: your_api_key"Full holdings, every historical snapshot, point-in-time queries, monthly returns and flows — free tier available, no card required.
Source: SEC EDGAR Form N-PORT. Data is quarterly with a regulatory filing lag; this page shows the most recent public filing. Not investment advice.